Shorts

0:46
Strategies for Anemia Management in Myelofibrosis
4 months ago
by
Raajit Rampal, MD, PhD

0:31
Financial Barriers Outweigh Race in Clinical Trial Enrollment
4 months ago
by
Richard Hoehn, MD

0:39
Managing Anemia and Transfusion Access Challenges
4 months ago
by
Raajit Rampal, MD, PhD

0:31
Predicting Cancer Outcomes with ctDNA Status in Bladder Cancer
4 months ago
by
Pooja Ghatalia, MD

0:39
PIM Inhibitor Shows Promise in High-Risk Myelofibrosis
4 months ago
by
Firas El Chaer, MD

0:24
More Than a Marker: Behind the Aggressive Nature of CD25+ Leukemias
4 months ago
by
Markus Müschen, MD, PhD

0:32
What’s Needed to Bring Clinical Trials to the Patient
4 months ago
by
Jason Hammonds

1:19
Can GLP-1 Agonists Help Treat Rare Cancers?
4 months ago
by
Erica Pimenta, MD, PhD

0:38
Initial Assessments in Metastatic RCC
4 months ago
by
David Braun, MD, PhD

0:35
The Future of Oncology Innovation is Moving to the Community
4 months ago
by
Jason Hammonds

0:36
Medicaid Expansion Saves Lives in Breast Cancer
4 months ago
by
Oluwasegun Akinyemi, MD, PhD

1:06
Understanding Co-Mutations and Real-Time ctDNA Monitoring in Lung Cancer
4 months ago
by
Estelamari Rodriguez, MD, MPH

0:32
Developing Novel Alpha-Emitting Agents in Prostate Cancer
4 months ago
by
Fred Saad, MD, FRCS

0:33
The Silent Crisis: Why Oncologists are Burning Out
4 months ago
by
Pallav K. Mehta, MD(+1 more)

0:38
The Future of Hybrid Healthcare
4 months ago
by
Pallav K. Mehta, MD(+1 more)

0:31
The Most 'Ripe' Areas for AI in Healthcare Right Now
4 months ago
by
Pallav K. Mehta, MD(+1 more)

0:33
The Challenge Isn't the Medicine—It's the Operations
4 months ago
by
Jason Hammonds

0:33
Predicting the Future: AI in the Medical Clinic
4 months ago
by
Chadi Nabhan, MD, MBA, FACP

0:29
How AI Could Have Saved More Lives 10 Years Ago
4 months ago
by
Chadi Nabhan, MD, MBA, FACP

0:44
How AI is Revolutionizing Precision Oncology
4 months ago
by
Chadi Nabhan, MD, MBA, FACP

0:38
Why Macrophages are the Future of Cancer Therapy
4 months ago
by
Paolo Strati, MD

0:58
Findings From LITESPARK-011 Poised for Treatment Shift in RCC
4 months ago
by
Rahul A. Parikh, MD

0:44
Molecular Profiling and Neoadjuvant Care in Gyn Cancers
4 months ago
by
Erin Crane, MD, MPH

0:43
How Academic and Community Centers Can Better Collaborate on CAR T
4 months ago
by
Marc S. Hoffmann, MD

0:44
Breakthrough in Bladder Cancer: The KEYNOTE-B15 Clinical Trial
4 months ago
by
Rahul A. Parikh, MD

0:40
Closing the Access Gap: The Vital Role of the "Enthusiastic Recommendation"
4 months ago
by
Marc S. Hoffmann, MD

0:50
The Hidden Bias in Medical AI Algorithms
4 months ago
by
Chadi Nabhan, MD, MBA, FACP

0:43
From Charting to Caring: How Technology and Delegation Save Clinician Time
4 months ago
by
Erin Crane, MD, MPH

0:32
The Search for a Functional Cure: Treating IGHV-Mutated CLL
4 months ago
by
Marc S. Hoffmann, MD

0:37
DNA Damage and Repair: Understanding pMMR and HRD in Gyn Cancers
4 months ago
by
Erin Crane, MD, MPH
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Divarasib Improves Survival Vs Approved KRAS G12C Inhibitors in NSCLC
2
Zoldonrasib Combos, Including With Daraxonrasib, Yield High Response Rates in PDAC
3
How a Virtual Behavioral Health Program Is Reaching Patients With Cancer Who Need It Most
4
Examining the Strongest Options for Heavily Pretreated Myeloma After Bispecific Therapy
5
